Learning Objectives

Thursday, April 18, 2024

Pharmacology Preconference

Hypertension: Responsive versus Resistant

1. Discuss the detection and management of hypertension through screening
2. Review guideline-directed medical therapy for responsive hypertension
3. Explore guideline-directed medical therapy for non-responsive resistant hypertension

Cognition and CVD: The Brain and the Heart

1. Define the shared relationship of CVD and brain health
2. Recognize the impact of pharmacological approaches on both CV health and brain health
3. Explain how to clinically examine cognition, interpret findings, and manage medications for the CV nurse

Hold What?! Cardiac Clearance for Cardiovascular Procedures

1. Discuss the process of cardiac screening for surgical/procedural interventions
2. Review anticoagulation drug classes to give or hold based on pharmacological effect
3. Discuss other drug class considerations in the preparation for interventional/surgical procedures

Weight Loss: Pharmacological Interventions Round Table

1. Review the epidemiology and pathophysiology of obesity, including the neurohormonal pathways that cause weight gain and prevent sustained weight loss.
2. Discuss the pharmacology and indications for the FDA-approved antiobesity medications (AOMs), including GLP1-RA’s, along with cardiac considerations of each.
3. Review other common obesity-inducing medications specific to the CV patient and considerations for combating these effects.
4. Discuss ethical considerations for prescribing AOM’s with the current environment surrounding these medications

General Sessions

Diversity, Health Equity, and Inclusion: National and Global Perspectives on CVD

1. Define and describe health disparities and the impact they have on cardiovascular health outcomes nationally and globally
2. Explain the importance of diversity in healthcare
3. Explore examples of initiatives or programs to promote patient cardiovascular outcome improvements
4. Outline steps that CV nurses and multi-disciplinary teams can take at the national and global levels to close gaps in health disparities and inequities

Spotlight on HFpEF: Heart Failure Guidelines

1. Review of guideline updates, including classification
2. Discuss HFpEF care and management
3. Examine the relationship of cardiometabolic disease and heart failure

Friday, April 19, 2024

Sleep: An Overdue Addition to Life’s Essential 8

1. Discuss the benefits of healthy sleep related to CVD
2. Review medical treatment of sleep-related breathing disorders
3. Discuss sleep therapies in the treatment of sleep-related diseases, including pharmacological approaches and CVD considerations

Management of Chronic Coronary Disease: 2023 Guidelines

1. Describe chronic coronary disease (CCD)
2. Discuss risk factors of CCD
3. Review CCD 2023 guideline highlighting pharmacological updates
4. Explain the implementation of guidelines into practice

Artificial Intelligence: Leveraging AI for CVD Management

1. Review the use of AI use in primary prevention and ongoing management of CVD
2. Discuss nursing considerations in the conceptualization and development of artificial intelligence
3. Explore the role of all CV nurses in real-world implementation

Transitions of Care (ToC) for the CVD patient

1. Identify evidence-based recommendations and key components of a ToC program, particularly for patients with heart failure and their families
2. Discuss the importance of an interdisciplinary ToC team, including psychosocial services to address social determinants of health-related barriers to treatment and to specialize in reducing cognitive and emotional barriers to engaging in recommended health behaviors
3. Review the role of education and empowering patients to access reliable healthcare information in a robust ToC program

Breakout: Workplace Violence: Techniques for defusing hostile scenarios

1. Review statistics of violence on healthcare workers
2. Recognize how to identify and respond to crisis
3. Demonstrate safe physical intervention techniques

Breakout: Murmurs: What’s the whoosh?

1. Review of abnormal heart sounds
2. Compare and contrast diastolic vs systolic murmurs
3. Discuss valve treatment options, including future technologies

Breakout: Remote Patient Monitoring in Heart Failure and Beyond

1. Review remote patient monitoring opportunities and evidence to support remote patient monitoring
2. Discuss hemodynamic monitoring tools in nursing and evidence to support the use of these in the HF population
3. Explore hospital-at-home capabilities and the future landscape of virtual nursing

Saturday, April 20, 2024

Prevention as Early Intervention

1. 1. Discuss the latest evidence in Life’s Essential 8
2. 2. Describe cutting-edge interventions to address Life’s Essential 8
3. 3. Explore the role of the CV nurse and interdisciplinary team in assessment and management

Women’s CVD and Hormonal Transitions Across the Lifespan

1. Discuss the impact of CV health in early life and effect of the pubescent hormonal transition
2. Discuss pregnancy as nature’s CV stress test and window into CVD risk for childbearing women
3. Explore the menopausal transition and the unique hormonal associations with CVD in women

Amplifying the Nurse’s Voice through Advocacy

1. Define the basics of advocacy in nursing
2. Review the levels of advocacy to find the fit for you
3. Describe tactics to transform you into an advocate (relationships, grassroots campaigns, townhall meetings, regulatory comments, coalition building)
4. Build your elevator speech

Accreditation Statement

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.